Ananda Ghosh
Stock Analyst at H.C. Wainwright
(4.74)
# 642
Out of 4,501 analysts
104
Total ratings
60.9%
Success rate
30.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACAD ACADIA Pharmaceuticals | Reiterated: Buy | $37 → $27 | $26.41 | +2.23% | 11 | Jul 7, 2026 | |
| PRQR ProQR Therapeutics | Maintained: Buy | $12 | $1.76 | +581.82% | 9 | Jun 29, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $110 | $32.42 | +239.30% | 19 | Jun 22, 2026 | |
| GPCR Structure Therapeutics | Rated: Buy | $100 → $70 | $55.14 | +26.95% | 19 | Jun 11, 2026 | |
| PEPG PepGen | Reiterated: Buy | $20 | $2.30 | +769.57% | 11 | May 29, 2026 | |
| SKYE Skye Bioscience | Maintained: Buy | $20 | $0.7009 | +2,753.47% | 7 | May 21, 2026 | |
| DYN Dyne Therapeutics | Maintained: Buy | $50 | $24.27 | +106.02% | 9 | May 21, 2026 | |
| STOK Stoke Therapeutics | Maintained: Buy | $50 | $32.83 | +52.30% | 10 | May 8, 2026 | |
| ANNX Annexon | Maintained: Buy | $14 | $5.94 | +135.69% | 5 | May 8, 2026 | |
| IVA Inventiva | Maintained: Buy | $24 | $4.53 | +429.80% | 4 | Jan 28, 2026 |
ACADIA Pharmaceuticals
Jul 7, 2026
Reiterated: Buy
Price Target: $37 → $27
Current: $26.41
Upside: +2.23%
ProQR Therapeutics
Jun 29, 2026
Maintained: Buy
Price Target: $12
Current: $1.76
Upside: +581.82%
Maze Therapeutics
Jun 22, 2026
Reiterated: Buy
Price Target: $110
Current: $32.42
Upside: +239.30%
Structure Therapeutics
Jun 11, 2026
Rated: Buy
Price Target: $100 → $70
Current: $55.14
Upside: +26.95%
PepGen
May 29, 2026
Reiterated: Buy
Price Target: $20
Current: $2.30
Upside: +769.57%
Skye Bioscience
May 21, 2026
Maintained: Buy
Price Target: $20
Current: $0.7009
Upside: +2,753.47%
Dyne Therapeutics
May 21, 2026
Maintained: Buy
Price Target: $50
Current: $24.27
Upside: +106.02%
Stoke Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $50
Current: $32.83
Upside: +52.30%
Annexon
May 8, 2026
Maintained: Buy
Price Target: $14
Current: $5.94
Upside: +135.69%
Inventiva
Jan 28, 2026
Maintained: Buy
Price Target: $24
Current: $4.53
Upside: +429.80%